Pan-cancer analysis of GJB5 as a novel prognostic and immunological biomarker
Abstract Gap junction protein B5 (GJB5, also known as Connexin 31.1) has recently been reported to be downregulated in several cancer types, where it functions primarily as a tumor suppressor in cancers such as melanoma and non-small cell lung cancer (NSCLC). However, there no reports describing its...
Saved in:
| Main Authors: | Xiaojuan Yang, Xunjie Cao, Qing Zhu, Hong Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-96389-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma
by: An Wang, et al.
Published: (2025-07-01) -
Pan-cancer analysis reveals immunological and prognostic significance of CCT5 in human tumors
by: Md. Zabir Ahmed, et al.
Published: (2025-04-01) -
Pan-cancer analysis and validation of NT5DC2: emphasizing its prognostic significance and immunological role in TNBC
by: Qing Luo, et al.
Published: (2025-07-01) -
Pan-cancer characterization of C–C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target
by: Wenming Zhao, et al.
Published: (2025-03-01) -
NOX4 serves as a pan-cancer prognostic biomarker and therapeutic target in tumorigenesis
by: Jiting Sun, et al.
Published: (2025-07-01)